{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:17:51Z","timestamp":1787588271972,"version":"build-2736575974"},"reference-count":86,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL164460"],"award-info":[{"award-number":["R01 HL164460"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021528","name":"Advancing a Healthier Wisconsin Endowment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021528","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","bmn.com","clinicalkey.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.tips.2024.02.001","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T08:15:03Z","timestamp":1709799303000},"page":"290-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Targeting mitochondrial dynamics and redox regulation in cardiovascular diseases"],"prefix":"10.1016","volume":"45","author":[{"given":"Mirza Ahmar","family":"Beg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Vick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.N. Shashanka","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9786-8305","authenticated-orcid":false,"given":"Yiliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2024.02.001_bb0005","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrd.2018.174","article-title":"Mitochondria as a therapeutic target for common pathologies","volume":"17","author":"Murphy","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2024.02.001_bb0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2006.06.007","article-title":"A CD36-dependent signaling cascade is necessary for macrophage foam cell formation","volume":"4","author":"Rahaman","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2024.02.001_bb0015","doi-asserted-by":"crossref","first-page":"ra91","DOI":"10.1126\/scisignal.aaa9623","article-title":"Oxidized LDL-bound CD36 recruits an Na(+)\/K(+)-ATPase-Lyn complex in macrophages that promotes atherosclerosis","volume":"8","author":"Chen","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tips.2024.02.001_bb0020","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1161\/ATVBAHA.108.179697","article-title":"Oxidized low-density lipoprotein and atherosclerosis","volume":"30","author":"Steinberg","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2024.02.001_bb0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.tips.2012.03.010","article-title":"Mitochondrial pharmacology","volume":"33","author":"Smith","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2024.02.001_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.729","article-title":"PCSK9 participates in oxidized-low density lipoprotein-induced myocardial injury through mitochondrial oxidative stress and Drp1-mediated mitochondrial fission","volume":"12","author":"Li","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.tips.2024.02.001_bb0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","article-title":"Mitochondrial dynamics and its involvement in disease","volume":"15","author":"Chan","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.tips.2024.02.001_bb0040","doi-asserted-by":"crossref","first-page":"12986","DOI":"10.1073\/pnas.1210718109","article-title":"Mitochondrial Ca2+ uptake contributes to buffering cytoplasmic Ca2+ peaks in cardiomyocytes","volume":"109","author":"Drago","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tips.2024.02.001_bb0045","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41580-020-0210-7","article-title":"The cell biology of mitochondrial membrane dynamics","volume":"21","author":"Giacomello","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tips.2024.02.001_bb0050","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1242\/jcs.185165","article-title":"Cooperative and independent roles of the Drp1 adaptors Mff, MiD49 and MiD51 in mitochondrial fission","volume":"129","author":"Osellame","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.tips.2024.02.001_bb0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2007.11.019","article-title":"Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax\/Bak-dependent mitochondrial outer membrane permeabilization","volume":"14","author":"Cassidy-Stone","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.tips.2024.02.001_bb0060","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.109.906610","article-title":"Inhibiting mitochondrial fission protects the heart against ischemia\/reperfusion injury","volume":"121","author":"Ong","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2024.02.001_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003872","volume":"5","author":"Ishikita","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.tips.2024.02.001_bb0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12967-023-04270-9","article-title":"Inhibition of DRP1-dependent mitochondrial fission by Mdivi-1 alleviates atherosclerosis through the modulation of M1 polarization","volume":"21","author":"Su","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tips.2024.02.001_bb0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cell.2017.08.041","article-title":"Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages","volume":"171","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2024.02.001_bb0080","doi-asserted-by":"crossref","first-page":"11562","DOI":"10.1096\/fj.201901039RR","article-title":"Mitochondrial division inhibitor 1 (mdivi-1) increases oxidative capacity and contractile stress generated by engineered skeletal muscle","volume":"34","author":"Rexius-Hall","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2024.02.001_bb0085","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCRESAHA.119.315833","article-title":"Mitochondrial metabolic reprogramming by CD36 signaling drives macrophage inflammatory responses","volume":"125","author":"Chen","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2024.02.001_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.839248","article-title":"Efferocytosis and its role in inflammatory disorders","volume":"10","author":"Ge","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tips.2024.02.001_bb0095","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159179","article-title":"MicroRNAs as therapeutic targets in cardiovascular disease","volume":"132","author":"Laggerbauer","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2024.02.001_bb0100","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2174\/1389201023666220324123224","article-title":"miR-199b-5p-AKAP1-DRP1 pathway plays a key role in ox-LDL-induced mitochondrial fission and endothelial apoptosis","volume":"23","author":"Cui","year":"2022","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.tips.2024.02.001_bb0105","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.3390\/ijms21144987","article-title":"AMPK, mitochondrial function, and cardiovascular disease","volume":"21","author":"Wu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2024.02.001_bb0110","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1016\/j.molcel.2021.08.025","article-title":"Inositol serves as a natural inhibitor of mitochondrial fission by directly targeting AMPK","volume":"81","author":"Hsu","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2024.02.001_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106003","article-title":"Activation of CD137 signaling promotes macrophage apoptosis dependent on p38 MAPK pathway-mediated mitochondrial fission","volume":"136","author":"Xu","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.tips.2024.02.001_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102828","article-title":"Epigenetic modulation of Drp1-mediated mitochondrial fission by inhibition of S-adenosylhomocysteine hydrolase promotes vascular senescence and atherosclerosis","volume":"65","author":"You","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.tips.2024.02.001_bb0125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/01616412.2017.1315864","article-title":"A review of sleep disorders and melatonin","volume":"39","author":"Xie","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.tips.2024.02.001_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12491","article-title":"Melatonin prevents Drp1-mediated mitochondrial fission in diabetic hearts through SIRT1-PGC1alpha pathway","volume":"65","author":"Ding","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.tips.2024.02.001_bb0135","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5298483","article-title":"Melatonin attenuates calcium deposition from vascular smooth muscle cells by activating mitochondrial fusion and mitophagy via an AMPK\/OPA1 signaling pathway","volume":"2020","author":"Chen","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.tips.2024.02.001_bb0140","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-14-6","article-title":"Role of homocysteine in the development of cardiovascular disease","volume":"14","author":"Ganguly","year":"2015","journal-title":"Nutr. J."},{"key":"10.1016\/j.tips.2024.02.001_bb0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/17512433.2015.1010516","article-title":"Homocysteine and the pathogenesis of atherosclerosis","volume":"8","author":"McCully","year":"2015","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.tips.2024.02.001_bb0150","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1111\/jcmm.14341","article-title":"Aberrant MFN2 transcription facilitates homocysteine-induced VSMCs proliferation via the increased binding of c-Myc to DNMT1 in atherosclerosis","volume":"23","author":"Xu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tips.2024.02.001_bb0155","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41589-022-01224-y","article-title":"Small molecule agonist of mitochondrial fusion repairs mitochondrial dysfunction","volume":"19","author":"Guo","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2024.02.001_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172987","article-title":"\u03ba-Opioid receptor activation promotes mitochondrial fusion and enhances myocardial resistance to ischemia and reperfusion injury via STAT3-OPA1 pathway","volume":"874","author":"Wang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2024.02.001_bb0165","doi-asserted-by":"crossref","first-page":"12246","DOI":"10.1111\/jcmm.15880","article-title":"Recent advances on the roles of LncRNAs in cardiovascular disease","volume":"24","author":"Fang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tips.2024.02.001_bb0170","article-title":"The lncRNA Punisher regulates apoptosis and mitochondrial homeostasis of vascular smooth muscle cells via targeting miR-664a-5p and OPA1","volume":"2022","author":"Yang","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.tips.2024.02.001_bb0175","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","article-title":"Physiological roles of mitochondrial reactive oxygen species","volume":"48","author":"Sena","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2024.02.001_bb0180","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/ATVBAHA.117.309228","article-title":"Reactive oxygen species generation and atherosclerosis","volume":"37","author":"Nowak","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2024.02.001_bb0185","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jchf.2014.06.008","article-title":"The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial","volume":"2","author":"Mortensen","year":"2014","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.tips.2024.02.001_bb0190","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1475-2891-12-142","article-title":"Effects of coenzyme Q10 supplementation (300 mg\/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial","volume":"12","author":"Lee","year":"2013","journal-title":"Nutr. J."},{"key":"10.1016\/j.tips.2024.02.001_bb0195","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3389\/fphar.2020.01034","article-title":"CoenzymeQ10-induced activation of AMPK-YAP-OPA1 pathway alleviates atherosclerosis by improving mitochondrial function, inhibiting oxidative stress and promoting energy metabolism","volume":"11","author":"Xie","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tips.2024.02.001_bb0200","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4158\/EP.12.5.576","article-title":"Vitamin E in humans: an explanation of clinical trial failure","volume":"12","author":"Robinson","year":"2006","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.tips.2024.02.001_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216385","article-title":"An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals","volume":"14","author":"Detaille","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2024.02.001_bb0210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10557-020-07113-7","article-title":"Effects of OP2113 on myocardial infarct size and no reflow in a rat myocardial ischemia\/reperfusion model","volume":"36","author":"Dai","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.tips.2024.02.001_bb0215","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1111\/bph.16174","article-title":"OP2113, a new drug for chronic hypoxia-induced pulmonary hypertension treatment in rat","volume":"180","author":"Roubenne","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2024.02.001_bb0220","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.exger.2012.08.007","article-title":"SIRT3 regulation of mitochondrial oxidative stress","volume":"48","author":"Bause","year":"2013","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.tips.2024.02.001_bb0225","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbrc.2013.10.033","article-title":"SIRT5 desuccinylates and activates SOD1 to eliminate ROS","volume":"441","author":"Lin","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2024.02.001_bb0230","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/CIRCRESAHA.119.315767","article-title":"Mitochondrial deacetylase Sirt3 reduces vascular dysfunction and hypertension while Sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress","volume":"126","author":"Dikalova","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2024.02.001_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24586","article-title":"SIRT3 attenuates coronary atherosclerosis in diabetic patients by regulating endothelial cell function","volume":"36","author":"Gong","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.tips.2024.02.001_bb0240","doi-asserted-by":"crossref","first-page":"14015","DOI":"10.1021\/acs.jmedchem.2c01215","article-title":"Potent and specific activators for mitochondrial Sirtuins Sirt3 and Sirt5","volume":"65","author":"Suenkel","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2024.02.001_bb0245","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2024.02.001_bb0250","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tips.2024.02.001_bb0255","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.bbamem.2006.02.015","article-title":"Membrane transport of hydrogen peroxide","volume":"1758","author":"Bienert","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2024.02.001_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101962","article-title":"AQP8 is a crucial H2O2 transporter in insulin-producing RINm5F cells","volume":"43","author":"Kruger","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.tips.2024.02.001_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.897666","article-title":"Aquaporin-8 transports hydrogen peroxide to regulate granulosa cell autophagy","volume":"10","author":"Huang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tips.2024.02.001_bb0270","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41467-022-28276-x","article-title":"Genetic associations with carotid intima-media thickness link to atherosclerosis with sex-specific effects in sub-Saharan Africans","volume":"13","author":"Boua","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2024.02.001_bb0275","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41569-021-00629-x","article-title":"Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis","volume":"19","author":"Chen","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.tips.2024.02.001_bb0280","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","article-title":"Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications","volume":"117","author":"Zielonka","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.tips.2024.02.001_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2022.100148","article-title":"A new triphenylphosphonium-conjugated amphipathic cationic peptide with improved cell-penetrating and ROS-targeting properties","volume":"4","author":"Ishkaeva","year":"2023","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"10.1016\/j.tips.2024.02.001_bb0290","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/acsnano.2c05286","article-title":"Intravenous transplantation of an ischemic-specific peptide-TPP-mitochondrial compound alleviates myocardial ischemic reperfusion injury","volume":"17","author":"Sun","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2024.02.001_bb0295","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1681\/ASN.2010080808","article-title":"Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury","volume":"22","author":"Szeto","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tips.2024.02.001_bb0300","article-title":"Chronic administration of mitochondrion-targeted peptide SS-31 prevents atherosclerotic development in ApoE knockout mice fed Western diet","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2024.02.001_bb0305","doi-asserted-by":"crossref","first-page":"19847","DOI":"10.1038\/s41598-022-24231-4","article-title":"Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice","volume":"12","author":"Russo","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2024.02.001_bb0310","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Zhou","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2024.02.001_bb0315","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/ijms23010112","article-title":"Resveratrol-encapsulated mitochondria-targeting liposome enhances mitochondrial respiratory capacity in myocardial cells","volume":"23","author":"Tsujioka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2024.02.001_bb0320","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.omtn.2020.04.004","article-title":"Validation of gene therapy for mutant mitochondria by delivering mitochondrial RNA using a MITO-Porter","volume":"20","author":"Kawamura","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tips.2024.02.001_bb0325","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.colsurfb.2017.11.048","article-title":"Negatively charged polypeptide-peptide nanoparticles showing efficient drug delivery to the mitochondria","volume":"162","author":"Cohen-Erez","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.tips.2024.02.001_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113650","article-title":"Acute myocardial infarction therapy using calycosin and tanshinone co-loaded mitochondria targeted lipid-polymer hybrid nano-system: Preparation, characterization, and anti myocardial infarction activity assessment","volume":"155","author":"Yan","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tips.2024.02.001_bb0335","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acs.nanolett.2c03958","article-title":"Nanoparticle-based artificial mitochondrial DNA transcription regulator: MitoScript","volume":"23","author":"Yang","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.tips.2024.02.001_bb0340","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41551-018-0221-2","article-title":"Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates","volume":"2","author":"Lameijer","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tips.2024.02.001_bb0345","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1021\/acsnano.9b08216","article-title":"Affinity-driven design of cargo-switching nanoparticles to leverage a cholesterol-rich microenvironment for atherosclerosis therapy","volume":"14","author":"Kim","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2024.02.001_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1046495","article-title":"Contribution of adipocyte Na\/K-ATPase alpha1\/CD36 signaling induced exosome secretion in response to oxidized LDL","volume":"10","author":"Pillai","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.tips.2024.02.001_bb0355","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.7150\/thno.56035","article-title":"Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.tips.2024.02.001_bb0360","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbad069","article-title":"Nature-inspired nanocarriers for improving drug therapy of atherosclerosis","volume":"10","author":"Ji","year":"2023","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.tips.2024.02.001_bb0365","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.tips.2024.02.001_bb0370","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jconrel.2020.11.064","article-title":"Platelet-derived extracellular vesicles to target plaque inflammation for effective anti-atherosclerotic therapy","volume":"329","author":"Ma","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tips.2024.02.001_bb0375","article-title":"Targeted delivery of platelet membrane modified extracellular vesicles into atherosclerotic plaque to regress atherosclerosis","volume":"452","author":"Qiyu Li","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.tips.2024.02.001_bb0380","doi-asserted-by":"crossref","first-page":"14925","DOI":"10.1021\/acsnano.2c05847","article-title":"Exosome-loaded pro-efferocytic vascular stent with Lp-PLA(2)-triggered release for preventing in-stent restenosis","volume":"16","author":"Zou","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2024.02.001_bb0385","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jacc.2020.12.060","article-title":"Mitochondria-rich extracellular vesicles from autologous stem cell-derived cardiomyocytes restore energetics of ischemic myocardium","volume":"77","author":"Ikeda","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tips.2024.02.001_bb0390","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cell.2020.08.031","article-title":"A network of macrophages supports mitochondrial homeostasis in the heart","volume":"183","author":"Nicolas-Avila","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tips.2024.02.001_bb0395","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.cmet.2022.08.010","article-title":"Dietary lipids inhibit mitochondria transfer to macrophages to divert adipocyte-derived mitochondria into the blood","volume":"34","author":"Borcherding","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2024.02.001_bb0400","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.cmet.2021.08.002","article-title":"Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes","volume":"33","author":"Crewe","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2024.02.001_bb0405","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tips.2024.02.001_bb0410","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/CIRCRESAHA.120.316903","article-title":"Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas","volume":"127","author":"Zernecke","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2024.02.001_bb0415","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tips.2024.02.001_bb0420","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1741-7015-11-117","article-title":"Immunity, atherosclerosis and cardiovascular disease","volume":"11","author":"Frostegard","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.tips.2024.02.001_bb0425","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tips.2024.02.001_bb0430","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.10.013","article-title":"The pathology of atherosclerosis: plaque development and plaque responses to medical treatment","volume":"122","author":"Insull","year":"2009","journal-title":"Am. J. Med."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614724000282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614724000282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T18:29:40Z","timestamp":1731522580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614724000282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0165614724000282"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2024.02.001","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting mitochondrial dynamics and redox regulation in cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2024.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}